The web-based ARV Ordering and Reporting System (WAOS) is the official Ministry of Health (MoH) ARV ordering and reporting system hosted within the District Health Information Software (DHIS2). Since 2013, the Ministry of Health uses the system to support health facilities to order for and report on utilization of ARVs and medicines for treatment of opportunistic infections. Health facilities with computers and internet connectivity submit orders directly into the WAOS. Facilities without computers and internet connectivity submit hard copy orders to district biostatisticians who enter the orders into the web-based system. In cases where hard copy orders are submitted directly to a central warehouse those orders are entered into WAOS at the warehouse.
Antiretroviral medicines Public sector: NMS is well stocked with ARV medicines above 3 MOS except EFV 600mg, ATV/r 300/100mg and LPV/r 100/25mg with less than 3 MOS. Stock is available in country for TDF/3TC/EFV 300/300/600mg (3.5 MOS), TDF/3TC/DTG 300/300/50mg (3.1 MOS), DTG 50mg (4.2 MOS), ABC/3TC 600/300mg (3.8 MOS), LPV/r 40/10mg pellets (5.2 MOS) and EFV 200mg (6.0 MOS). Transfer stock from JMS to NMS has been effected for DTG 50mg (2.2 MOS), ABC/3TC 600/300mg (2.6 MOS), EFV 200mg (2.8 MOS) and LPV/r 40/10mg pellets (1.8 MOS). Orders for ARV commodities have been placed under GF for CY 2020. Shipments for LPV/r formulations have been delayed due to the current global shortage of LPV/r. Consumption of LPV/r and ABC/3TC based formulations is expected to increase following regimen optimization for Children to LPV/r and DTG based formulations. PNFP sector: JMS is well stocked on ARV formulations (> 3MOS) except DTG 50mg and AZT/3TC 300/150mg. Shipments for AZT/3TC 300/150mg (15.8 MOS) and DTG 50mg (15.2 MOS) are expected in June 2020. There is an overstock of AZT/3TC/NVP 60/30/50mg, NVP syrup and EFV 200mg. Consumption of these commodities has reduced due to pediatric regimen optimization. At MAUL, ARV medicines are well stocked with more than 3 MOS except for LPV/r 200/50mg. A shipment of LPV/r 200/50 mg (4.3MOS) is expected by end of February 2020. An order needs to be placed by MAUL for TDF/3TC 300/300mg to avert the projected low stock levels starting in March 2020.
A standard operating procedure (SOP) is a set of systematic instructions compiled by an organization to help workers carry out complex routine operations. SOPs aim to achieve efficiency, quality output and uniformity of performance, while reducing miscommunication and failure to comply with regulations. They also help ease the process of handing over duties from one staff to another.
This report enables us to see for the first time that the number of people using tobacco in the world is declining, despite population growth. The number of male tobacco users, which previously was increasing every year, finally turned the corner in 2018 and is projected to decline each year from 2019 forward. For this projection to become reality, tobacco control efforts need to be reinforced, and in some countries accelerated, to prevent additional people falling victim to tobacco-related illnesses and death.
The three strategic priorities of WHO stated in its Thirteenth General Programme of Work 2019–2023 are to advance universal health coverage, address health emergencies and promote healthier populations (1). The WHO Model List of Essential Medicines contains the medications considered to be the most effective and safe to meet the most important needs in a health system, thus advancing these strategic priorities
The purpose of this report is to inform the Ministry of Health and all stakeholders of the stock levels in the country as a tool that enables appropriate logistics decision making . This report highlights stock status, real challenges, bottlenecks but also recommends potential solutions to mitigate stock outs and expiries of ARVs & HIV test kits, ACTs, Anti-TB medicines, Reproductive Health items, selected Laboratory commodities, Vaccines and selected medicines for treatment of Opportunistic Infections In the Republic of UgandaThis report serves to: - Act as an early warning indicator for potential stock outs and possible expiries of EMHS- Identify challenges and recommendations to avert supply interruptions- Encourage preparation and sharing of joint supply plans with stakeholders- Identify strategies for regularly reviewing supply plans for all the commodities - Encourage donors to honour their commitments in terms of quantities of products expected, timeliness of deliveries and flexibility
This manual describes how to manage supplies based on revised and harmonized tools. It will act as a reference guide for health workers and focus on basic principles of supply chain management. If properly followed, it will promote efficient stock control and ordering of all EMHS. Health workers at all levels of care in the public sector are encouraged to use the stock management system described herein
The thirty-eighth meeting of the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 14 to 18 November 2016. Dr Suzanne Hill, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting. She welcomed all participants on behalf of the WHO Director-General.
The Fifty-third meeting of the World Health Organization (WHO) Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP) took place in Geneva, Switzerland, from 22 to 26 October 2018. Participants of the meeting were welcomed by Dr Mariângela Simão, Assistant Director-General, Access to Medicines, Pharmaceuticals and Vaccines, on behalf of the WHO Director-General, Dr Tedros Ghebreyesus. Dr Simão described the Director-General’s vision as:
About 275 million people worldwide, which is roughly 5.6 per cent of the global population aged 15–64 years, used drugs at least once during 2016. Some 31 million of people who use drugs suffer from drug use disorders, meaning that their drug use is harmful to the point where they may need treatment. Initial estimations suggest that, globally, 13.8 million young people aged 15–16 years used cannabis in the past year, equivalent to a rate of 5.6 per cent.
Procurement planning is an annual exercise conducted by Health Facilities (HFs) countrywide with technical assistance from National Medical Stores (NMS) and under the supervision of Ministry of Health (MoH) with the objective of quantifying or determining facility pharmaceutical needs for the next financial year. The exercise involved quantifying for credit Line (CRL) commodities using pre-designed templates customized by level of care and also forecasting for centrally managed programs whose planning was conducted by MoH (QPPU).
National quantification of EMHLS is an annual exercise conducted by NMS under the direct supervision of MoH, and the exercise is intended to provide all public sector players/stakeholder in the health sector with feedback about facility needs in accordance with the NMS Act Cap 207 that states in part that the Corporation shall advise the Ministry of Health, Ministry of Finance, Planning and Economic Development, Ministry of Local Government and National Drug Authority on essential issues relating to the state of the Corporation and its future development as well as to related matters including the estimation of drug needs, distribution and use of medicines in the public health service.
